Similarly, in prostate cancer cells, histone H3K9me3 modification abrogated TEs transcription and the subsequent RIG-I/MDA5-MAVS signaling, leading to the resistance of anti-androgen therapy (26). This evidence concerns the gene RIGI and prostate carcinoma.